NEW YORK , May 28, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact...
Azenta, Inc. reaffirmed 3%-5% organic revenue growth and 300 basis points of margin expansion in February 2026 -- then cut both targets three months later after recording a $149 million goodwill impairment....
New York, New York--(Newsfile Corp. - May 25, 2026) - Levi & Korsinsky notifies investors that it has commenced an investigation into Azenta, Inc. (NASDAQ: AZTA) ("Azenta, Inc.") concerning potential violations...
Law Offices of Howard G. Smith continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA ) investors concerning the Company’s possible violations...
The Law Offices of Frank R. Cruz continues its investigation of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA ) on behalf of investors concerning the Company’s...
Glancy Prongay Wolke & Rotter LLP , a leading national shareholder rights law firm, continues its investigation on behalf of Azenta, Inc. (“Azenta” or the “Company”) (NASDAQ: AZTA...
BURLINGTON, Mass. , May 21, 2026 /PRNewswire/ -- Azenta, Inc. (Nasdaq: AZTA) today announced the publication of its annual Environmental, Social, & Governance ("ESG") report, demonstrating continued...
NEW YORK , May 21, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Azenta, Inc. ("Azenta" or the "Company") (NASDAQ: AZTA). Such investors are advised to contact...
Azenta, Inc. reported Q2 FY 2026 results that included a $160.8 million net loss and a $149 million goodwill impairment -- erasing prior guidance and shareholder value.
Winners And Losers Of Q1: Azenta (NASDAQ:AZTA) Vs The Rest Of The Drug Development Inputs & Services Stocks